Regents of the Univ. of Minn. v. Gilead Scis., Inc.

299 F. Supp. 3d 1034
CourtDistrict Court, D. Maine
DecidedOctober 20, 2017
DocketCivil No. 16–CV–2915 (SRN/HB)
StatusPublished
Cited by6 cases

This text of 299 F. Supp. 3d 1034 (Regents of the Univ. of Minn. v. Gilead Scis., Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Regents of the Univ. of Minn. v. Gilead Scis., Inc., 299 F. Supp. 3d 1034 (D. Me. 2017).

Opinion

SUSAN RICHARD NELSON, United States District Court Judge

Before the Court is Defendant's Motion to Transfer Venue [Doc. No. 142]. For the reasons stated herein, Defendant's Motion is granted, and this case is transferred to the Northern District of California.

I. BACKGROUND

In this patent infringement suit, the Regents of the University of Minnesota ("the University") allege that Gilead Sciences, Inc. ("Gilead") infringes the University's intellectual property rights in a patent for a drug known as sofosbuvir. (Compl. ¶ 3 [Doc. No. 1].) Sofosbuvir is an antiviral agent used to treat the hepatitis C virus ("HCV") infections. (See id. ¶ 41.) The University holds all rights to the patent at issue (the '830 Patent). (id. ¶ 33.) The University alleges that Gilead has infringed the '830 Patent by selling over one billion dollars in sofosbuvir-containing medicines, including Gilead's Sovaldi®, Harvoni®, *1037and Epclusa® brand-name medicines, without obtaining the University's authorization or otherwise compensating the University. (Id. ¶¶ 3; 46-55.)

A. Factual Background

Gilead is a Delaware corporation, with its principal place of business in Foster City, California. (Id. ¶ 2.) Between 2014 and 2016, Gilead employed the following twelve employees in Minnesota in the positions of Regional Sales Director, Therapeutic Specialist, Community Specialist, and Medical Scientist: Chad Blomgren, Mary Ellen Feldstein, Byron Hamilton, Tracey Johnson, Ajit Kulkarni, Joe Llewellyn, Julie Miller, Carson Munroe, Jaymee Murakami, Christi Murphy, Allison Passolt, and Thomas Wolfe.1 (Def.'s Resp. to Pl.'s Second Set of Interrogs., Interrog. Resp. No. 5, Ex. A to Minarik Decl. [Doc. No. 157]; D. Johnson Decl. ¶ 5 [Doc. No. 145].)

A majority of the twelve employees work in sales and marketing positions as Therapeutic Specialists or Community Specialists, or as managers of those positions. (See Passolt Decl. ¶¶ 2-3 [Doc. No. 147]; Miller Decl. ¶¶ 2-3 [Doc. No. 152]; Vogel Decl. ¶¶ 4-5 [Doc. No. 1154]; Wolfe Decl. ¶¶ 2-3 [Doc. No. 155]; T. Johnson Decl. ¶¶ 2-3 [Doc. No. 156]; Hamilton Decl. ¶ 4 [Doc. No. 148]; Blomgren Decl. ¶ 4 [Doc. No. 149].) Therapeutic Specialists visit and educate "learned intermediaries," such as health care providers, hospitals, and pharmacies, about Gilead's products, and Community Specialists also visit learned intermediaries, as well as community groups. (See D. Johnson Decl. ¶¶ 4; 6; see also D. Johnson Dep. at 14-15, Ex. E to Hrycyszyn Decl.) Therapeutic Specialists and Community Specialists also occasionally plan local exhibits or conferences. (Id. ) (See D. Johnson Decl. ¶ 6 [Doc. No. 145]; D. Johnson Dep. at 9, Ex. E to Hrycyszyn Decl.) David Johnson, Gilead's Vice President of Sales and Marketing, Liver Disease Unit, asserts that while these are sales positions, "sales" in the pharmaceutical industry do not involve direct sales from the salesperson to the customer. (See D. Johnson Dep. at 13-15, Ex. E to Hrycyszyn Decl.) Rather, pharmaceutical salespersons attempt to sway medical providers to prescribe particular medications to their patients. (See id. ) Consistent with Johnson's testimony, Gilead's Minnesota Therapeutic Specialists, Community Specialists, and their managers contend that they do not take orders from customers or solicit sales directly from distributors, wholesalers, pharmacies, or pharmacy benefit managers. (Passolt Decl. ¶ 10; Hamilton Decl. ¶ 10; Blomgren Decl. ¶ 11; Murphy Decl. ¶ 10 [Doc. No. 150]; Miller Decl. ¶ 11; Feldstein Decl. ¶ 10; Vogel Decl. ¶ 9; Wolfe Decl. ¶ 10; T. Johnson Decl. ¶ 11.)

Gilead's Medical Scientists in Minnesota respond to questions from healthcare providers about Gilead's products, and coordinate experiments and clinical projects regarding Gilead's various drug therapies. (See D. Johnson Decl. ¶ 4; Kulkarni Decl. ¶ 4 [Doc. No. 146]; Llewellyn Decl. ¶ 5 [Doc. No. 151].) Like the Therapeutic Specialists and Community Specialists, Medical Scientists do not take customers' orders or make direct sales. (Kulkarni Decl. ¶ 10; Llewellyn Decl. ¶ 11.)

Through its headquarters in Foster City, California, Gilead sells its healthcare products to wholesalers or pharmacies. (D. Johnson Decl. ¶ 7.) Gilead's Minnesota sales force likewise understands that all orders are placed with corporate headquarters in California. (Kulkarni Decl. ¶ 10; Passolt Decl. ¶ 10; Hamilton Decl.

*1038¶ 10; Murphy Decl. ¶ 10; Llewellyn Decl. ¶ 11; Miller Decl. ¶ 11; Wolfe Decl. ¶ 10; T. Johnson Decl. ¶ 11.)

Three Minnesota employees perform a greater portion of their work outside of Minnesota, (Kulkarni Decl. ¶ 5; Hamilton Decl. ¶ 5; Miller Decl. ¶ 5), as was also true of another employee, during the time that he lived in Minnesota. (Blomgren Decl. ¶ 6.) Yet another employee splits her time equally between Minnesota and a neighboring state, (T. Johnson Decl. ¶ 5), while six others perform the majority of their work in Minnesota. (Passolt Decl. ¶ 5; Murphy Decl. ¶ 5; Llewellyn Decl. ¶ 6; Feldstein Decl. ¶ 5; Wolfe Decl. ¶ 5; T. Johnson Decl. ¶ 5.)

None of the employees work from a physical Gilead office in Minnesota. (Kulkarni Decl. ¶ 5; Passolt Decl. ¶ 5; Hamilton Decl. ¶ 5; Blomgren Decl. ¶ 6; Murphy Decl. ¶ 5; Llewellyn Decl. ¶ 6; Miller Decl. ¶ 5; Feldstein Decl. ¶ 5; Vogel Decl. ¶ 7; Wolfe Decl. ¶ 5; T. Johnson Decl.) Instead, they perform the majority of their work "in the field," i.e., in health care providers' offices, clinics, hospitals, and pharmacies. (Id. )

When they are not working in the field, the employees work from their respective home offices, as opposed to a separate, physical Gilead office in Minnesota.2 (Kulkarni Decl. ¶ 7; Passolt Decl. ¶ 7; Hamilton Decl. ¶¶ 5; 7; Blomgren Decl. ¶ 7; Murphy Decl. ¶¶ 5; 7; Llewellyn Decl. ¶¶ 6; 8; Miller Decl. ¶¶ 5; 7; Feldstein Decl. ¶ 7; Wolfe Decl. ¶ 7; T. Johnson Decl. ¶ 7.) Two employees have taken a tax deduction for their home office at some point, (Kulkarni Decl. ¶ 7; Miller Decl. ¶ 7), although the majority have not. (Passolt Decl. ¶ 7; Hamilton Decl. ¶ 7; Blomgren Decl. ¶ 7; Murphy Decl. ¶ 7; Feldstein Decl. ¶ 7; Wolfe Decl. ¶ 7 ; T. Johnson Decl. ¶ 7.)

Gilead's Minnesota employees do not use an administrative or secretarial service in this state or elsewhere. (Kulkarni Decl. ¶ 7; Passolt Decl. ¶ 7; Hamilton Decl. ¶ 7; Blomgren Decl. ¶ 7; Murphy Decl. ¶ 7; Llewellyn Decl. ¶ 8; Miller Decl. ¶ 7; Feldstein Decl. ¶ 7; Wolfe Decl. ¶ 7; T. Johnson Decl. ¶ 7.) Their respective home offices contain a computer, printer, and iPad provided by Gilead (Kulkarni Decl. ¶ 7; Passolt Decl. ¶ 7; Hamilton Decl. ¶ 7; Blomgren Decl. ¶ 7; Murphy Decl. ¶ 7; Llewellyn Decl. ¶ 8; Miller Decl. ¶ 7; Feldstein Decl. ¶ 7; Vogel Decl. ¶ 8; Wolfe Decl. ¶ 7; T. Johnson Decl. ¶ 7), and in one instance, a projector. (Murphy Decl. ¶ 7.) Gilead pays for its employees' home phone, internet, a portion of their monthly cell phone bills, and the lease on their vehicles. (Kulkarni Decl. ¶ 9; Passolt Decl. ¶ 9; Hamilton Decl. ¶ 9; Blomgren Decl. ¶ 10; Murphy Decl. ¶ 7; Llewellyn Decl. ¶ 10; Miller Decl. ¶ 9; Feldstein Decl. ¶ 9; Vogel Decl. ¶ 8; Wolfe Decl. ¶ 9; T. Johnson Decl.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
299 F. Supp. 3d 1034, Counsel Stack Legal Research, https://law.counselstack.com/opinion/regents-of-the-univ-of-minn-v-gilead-scis-inc-med-2017.